Identification of five novel mutations in the factor XI gene (F11) of patients with factor XI deficiency

Blood Coagulation and Fibrinolysis

Volumn 17, Issue 1, 2006, Pages 69-73

  Quélin, Florence ^a,b   Mathonnet, Florence ^c   Potentini Esnault, Catherine ^d   Trigui, Nawel ^a,b   Peynet, Jocelyne ^e   Bastenaire, Brigitte ^e   Guillon, Laurent ^a,b   Bigel, Marie Laure ^f   Sauger, Annick ^d   Mazurier, Claudine ^d   De Mazancourt, Philippe ^a,b  

^a RAYMOND POINCARÉ HOSPITAL   (France)

^b INRA Institut National de la Recherche Agronomique   (France)

^c CENTRE HOSPITALIER INTERCOMMUNAL   (France)

^d Laboratoire Français du Fractionnement et des Biotechnologies   (France)

^e Centre de Traitement des Hémophiles   (France)

^f Service de réanimation médico chirurgicale Centre hospitalier François Quesnay   (France)

Author keywords

Factor XI; Factor XI deficiency; Mutation

Indexed keywords

BLOOD CLOTTING FACTOR 11; LEUCINE; SERINE; SIGNAL PEPTIDE;

ADULT; AGED; ARTICLE; BLOOD CLOTTING FACTOR 11 DEFICIENCY; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; EXON; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MALE; MISSENSE MUTATION; MOLECULAR GENETICS; PRIORITY JOURNAL;

EID: 31644442634     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000198054.50257.96     Document Type: Article

References (35)

1. Davie EW, Fujikawa K, Kurachi K, Kisiel W. The role of serine proteases in the blood coagulation cascade. Adv Enzymol Relat Areas Mol Biol 1979; 48:277-318.
2. Gailani D, Ho D, Sun MF, Cheng Q, Walsh PN. Model for a factor IX activation complex on blood platelets: dimeric conformation of factor XIa is essential. Blood 2001; 97:3117-3122.
3. Davie EW, Fujikawa K, Kisiel W. The coagulation cascade: initiation, maintenance and regulation. Biochemistry 1991; 30:10363-10370.
4. Clarkson K, Rosenfeld B, Fair J, Klein A. Factor XI deficiency acquired by liver transplantation. Ann Intern Med 1991; 115:877-879.
5. McMullen BA, Fujikawa K, Davie EW. Location of the disulfide bonds in human coagulation factor XI: the presence of tandem apple domains. Biochemistry 1991; 30:2056-2060.
6. Asakai R, Davie EW, Chung DW. Organization of the gene for human factor XI. Biochemistry 1987; 26:7221-7228.
7. Kato A, Asakai R, Davie EW, Aoki N. Factor XI gene (F11) is located on the distal end of the long arm of human chromosome 4. Cytogenet Cell Genet 1989; 52:77-78.
8. Shpilberg O, Peretz H, Zivelin A, Yatuv R, Chetrit A, Kulka T, et al. One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqui Jews, who represent the ancient gene pool of Jews. Blood 1995; 85:429-432.
9. Dossenbach-Glaninger A, Hopmeier P. Coagulation factor XI: a database of mutations and polymorphisms associated with factor XI deficiency. Blood Coagul Fibrinolysis 2005; 16:231-238.
10. Asakai R, Chung DW, Ratnoff OD, Davie EW. Factor XI (plasma thromboplastin antecedent) deficiency in Ashkenazi Jews is a bleeding disorder that can result from three types of point mutations. Proc Natl Acad Sci USA 1989; 86:7667-7671.
11. Peretz H, Zivelin A, Usher S, Seligsohn U. A 14-bp deletion (codon 554 del AAGgtaacagagtg) at exon 14/intron N junction of the coagulation factor XI gene disrupts splicing and causes severe factor XI deficiency. Hum Mut 1996; 8:77-78.
12. Ragni MV, Sinha D, Seaman F, Lewis JH, Spero JA, Walsh PN. Comparison of bleeding tendency, factor XI coagulation activity, and factor XI antigen in 25 factor XI-deficient kindreds. Blood 1985; 65:719-724.
13. Kravtsov DV, Wu W, Meijers JC, Sun MF, Blinder MA, Dang TP, et al. Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain. Stood 2004; 104:128-134.
14. Kravtsov DV, Monahan PE, Gailani D. A classification system for cross-reactive material negative factor XI deficiency. Blood 2005; 105:4671-4673.
15. Rosenthal RL, Dreskin OH, Rosenthal N. New hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor. Proc Soc Exp Biol Med 1953; 82:171-174.
16. Bolton-Maggs PHB, Wan-Yin BY, McCraw AH, Slack J, Kernoff PBA. Inheritance and bleeding in factor XI deficiency. Br J Haematol 1988; 69:521-528.
17. Smith JK. Factor XI deficiency and its management. Haemophilia 1996; 2:128-136.
18. Todd M, Wright IS. Factor XI (PTA) deficiency with no hemorrhagic symptoms. Thromb Diath Haemorrh 1964; 11:186-194.
19. Kawaguchi T, Koga S, Hongo H, Komiyama Y, Li K, Ishihara S, et al. A novel type of factor XI deficiency showing compound genetic abnormalities: a nonsense mutation and an impaired transcription. Int J Hematol 2000; 71:84-89.
20. Fujikawa K, Chung DW, Hendrickson LE, Davie EW. Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein. Biochemistry 1986; 25:2417-2424.
21. Keenan RJ, Freymann DM, Stroud RM, Walter P. The signal recognition particle. Annu Rev Biochem 2001; 70:755-775.
22. Zhang Z, Henzel WJ. Signal peptide prediction based on analysis of experimentally verified cleavage sites. Protein Sci 2004; 13:2819-2824.
23. Bauduer F, Ducout L. Is the assessment of von Willebrand disease prevalence an achievable challenge? The example of the French basque country where blood group O and factor XI deficiency are highly prevalent. J Thromb Haemost 2004; 2:1724-1726.
24. Germanos-Haddad M, de Moerloose P, Boehlen F, Peyvandi F, Neerman-Arbez M. Homozygosity for a Thr575Met missense mutation in the catalytic domain associated with factor XI deficiency. Haematologica 2005; 90:418-419.
25. Mitchell M, Cutler C, Thompson S, Moore. Jenkins AP, Rees E, et al. Heterozygous factor XI deficiency associated with three novel mutations. Br J Haematol 1999; 107:763-765.
26. Mitchell M, Harrington P, Cutler J, Rangarajan S, Savidge G, Alhaq A. Eighteen unrelated patients with factor XI deficiency, four novel mutations and a 100% detection rate by denaturing high-performance liquid chromatography. Br J Haematol 2003; 121:500-502.
27. Zivelin A, Bauduer F, Kornbrot N, Ducout L, Rosenberg N, Seligsohn U. Identification of 5 novel factor XI mutations in French Basques [abstract]. Haematologica 1999; 84(Suppl 2):0549.
28. Tarumi T, Kravtsov DV, Moore JH, Williams SM, Gailani D. Common single nucleotide polymorphisms in the promoter region of the human factor XI gene. J Thromb Haemost 2003; 1:1854-1856.
29. Zhang B, Cunningham MA, Nichols WC, Bernat JA, Seligsohn U, Pipe SW, et al. Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex. Nat Genet 2003; 34:220-225.
30. Zivelin A, Bauduer F, Ducout L, Peretz H, Rosenberg N, Yatuv R, et al. Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the FXI gene. Blood 2002; 99:2448-2454.
31. Quélin F, Trossaërt M, Sigaud M, de Mazancourt P, Fressinaud E. Molecular basis of severe factor XI deficiency in seven families from the west of France. Seven novel mutations, including an ancient Q88X mutation. J Thromb Haemost 2004; 2:71-76.
32. Pugh RE, McVey JH, Tuddenham EGD, Hancock JF. Six point mutations that cause factor XI deficiency. Blood 1995; 85:1509-1516.
33. Gailani D, Baglia FA, Sun MF, Ho D, Martincic D, Ware RE, et al. Factor XI-Asn 248: a variant with a platelet binding defect [abstract]. Thromb Haemost 2001; 86:OC1028.
34. Gailani D, Bolton-Maggs PH, Blinder M, Butler R, Mountford R, Heiny M, et al. Amino acid substitutions in the factor XI catalytic domain associated with factor XI deficiency. Thromb Haemost 2001; 86:P1112.
35. Zivelin A, Ogawa T, Bulvik S, Landau M, Toomey JR, Lane J, et al. Severe factor XI deficiency caused by a Gly555 to Glu mutation (factor XI-Glu555): a cross-reactive material positive variant defective in factor IX activation. J Thromb Haemost 2004; 2:1782-1789.